107 related articles for article (PubMed ID: 23782099)
1. Molecular dynamics investigation on the poor sensitivity of A171T mutant NEDD8-activating enzyme (NAE) for MLN4924.
Verma S; Singh A; Mishra A
J Biomol Struct Dyn; 2014; 32(7):1064-73. PubMed ID: 23782099
[TBL] [Abstract][Full Text] [Related]
2. A gatekeeper residue for NEDD8-activating enzyme inhibition by MLN4924.
Toth JI; Yang L; Dahl R; Petroski MD
Cell Rep; 2012 Apr; 1(4):309-16. PubMed ID: 22832224
[TBL] [Abstract][Full Text] [Related]
3. Mutations in UBA3 confer resistance to the NEDD8-activating enzyme inhibitor MLN4924 in human leukemic cells.
Xu GW; Toth JI; da Silva SR; Paiva SL; Lukkarila JL; Hurren R; Maclean N; Sukhai MA; Bhattacharjee RN; Goard CA; Medeiros B; Gunning PT; Dhe-Paganon S; Petroski MD; Schimmer AD
PLoS One; 2014; 9(4):e93530. PubMed ID: 24691136
[TBL] [Abstract][Full Text] [Related]
4. Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ.
Brownell JE; Sintchak MD; Gavin JM; Liao H; Bruzzese FJ; Bump NJ; Soucy TA; Milhollen MA; Yang X; Burkhardt AL; Ma J; Loke HK; Lingaraj T; Wu D; Hamman KB; Spelman JJ; Cullis CA; Langston SP; Vyskocil S; Sells TB; Mallender WD; Visiers I; Li P; Claiborne CF; Rolfe M; Bolen JB; Dick LR
Mol Cell; 2010 Jan; 37(1):102-11. PubMed ID: 20129059
[TBL] [Abstract][Full Text] [Related]
5. Nedd8-Activating Enzyme Is a Druggable Host Dependency Factor of Human and Mouse Cytomegalovirus.
Flores-Martínez YA; Le-Trilling VTK; Trilling M
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452475
[TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics simulation on the low sensitivity of mutants of NEDD-8 activating enzyme for MLN4924 inhibitor as a cancer drug.
Rashidieh B; Valizadeh M; Assadollahi V; Ranjbar MM
Am J Cancer Res; 2015; 5(11):3400-6. PubMed ID: 26807320
[TBL] [Abstract][Full Text] [Related]
7. Quantifiable analysis of cellular pathway inhibition of a Nedd8-activating enzyme inhibitor, MLN4924, using AlphaScreen.
Yan ZH; Burkhardt A; Loke HK; Chen J; Xu Q; Brauer P; Ma J; Lin Y; Garcia K; Dick LR; Bembenek ME
Anal Biochem; 2013 Aug; 439(2):109-15. PubMed ID: 23624319
[TBL] [Abstract][Full Text] [Related]
8. Absolute quantification of E1, ubiquitin-like proteins and Nedd8-MLN4924 adduct by mass spectrometry.
Yang X; Brownell JE; Xu Q; Zhu F; Ma J; Loke HK; Rollins N; Soucy TA; Minissale JJ; Thomas MP; Mallender WD; Dick LR; Li P; Liao H
Cell Biochem Biophys; 2013 Sep; 67(1):139-47. PubMed ID: 23754621
[TBL] [Abstract][Full Text] [Related]
9. Treatment-emergent mutations in NAEβ confer resistance to the NEDD8-activating enzyme inhibitor MLN4924.
Milhollen MA; Thomas MP; Narayanan U; Traore T; Riceberg J; Amidon BS; Bence NF; Bolen JB; Brownell J; Dick LR; Loke HK; McDonald AA; Ma J; Manfredi MG; Sells TB; Sintchak MD; Yang X; Xu Q; Koenig EM; Gavin JM; Smith PG
Cancer Cell; 2012 Mar; 21(3):388-401. PubMed ID: 22439935
[TBL] [Abstract][Full Text] [Related]
10. Structure-based repurposing of FDA-approved drugs as inhibitors of NEDD8-activating enzyme.
Zhong HJ; Liu LJ; Chan DS; Wang HM; Chan PW; Ma DL; Leung CH
Biochimie; 2014 Jul; 102():211-5. PubMed ID: 24657219
[TBL] [Abstract][Full Text] [Related]
11. The NEDD8-activating enzyme inhibition with MLN4924 sensitizes human cancer cells of different origins to apoptosis and necroptosis.
El-Mesery M; Anany MA; Hazem SH; Shaker ME
Arch Biochem Biophys; 2020 Sep; 691():108513. PubMed ID: 32721435
[TBL] [Abstract][Full Text] [Related]
12. The NEDD8 activating enzyme inhibitor MLN4924 mitigates doxorubicin-induced cardiotoxicity in mice.
Chen KH; Sun JM; Lin L; Liu JW; Liu XY; Chen GD; Chen H; Chen ZY
Free Radic Biol Med; 2024 Jul; 219():127-140. PubMed ID: 38614228
[TBL] [Abstract][Full Text] [Related]
13. Nedd8-activating enzyme inhibitor MLN4924 (Pevonedistat), inhibits miR-1303 to suppress human breast cancer cell proliferation via targeting p27
Chen Y; Du M; Yusuying S; Liu W; Tan Y; Xie P
Exp Cell Res; 2020 Jul; 392(2):112038. PubMed ID: 32360865
[TBL] [Abstract][Full Text] [Related]
14. The NEDD8-activating enzyme inhibitor MLN4924 sensitizes a TNFR1
El-Mesery M; Rosenthal T; Rauert-Wunderlich H; Schreder M; Stühmer T; Leich E; Schlosser A; Ehrenschwender M; Wajant H; Siegmund D
Cell Death Dis; 2019 Aug; 10(8):611. PubMed ID: 31406107
[TBL] [Abstract][Full Text] [Related]
15. Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses
Cooper J; Xu Q; Zhou L; Pavlovic M; Ojeda V; Moulick K; de Stanchina E; Poirier JT; Zauderer M; Rudin CM; Karajannis MA; Hanemann CO; Giancotti FG
Mol Cancer Ther; 2017 Aug; 16(8):1693-1704. PubMed ID: 28468780
[TBL] [Abstract][Full Text] [Related]
16. Nedd8-activating enzyme inhibitor MLN4924 provides synergy with mitomycin C through interactions with ATR, BRCA1/BRCA2, and chromatin dynamics pathways.
Garcia K; Blank JL; Bouck DC; Liu XJ; Sappal DS; Hather G; Cosmopoulos K; Thomas MP; Kuranda M; Pickard MD; Liu R; Bandi S; Smith PG; Lightcap ES
Mol Cancer Ther; 2014 Jun; 13(6):1625-35. PubMed ID: 24672057
[TBL] [Abstract][Full Text] [Related]
17. The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDR.
Zhou L; Chen S; Zhang Y; Kmieciak M; Leng Y; Li L; Lin H; Rizzo KA; Dumur CI; Ferreira-Gonzalez A; Rahmani M; Povirk L; Chalasani S; Berger AJ; Dai Y; Grant S
Blood; 2016 May; 127(18):2219-30. PubMed ID: 26851293
[TBL] [Abstract][Full Text] [Related]
18. MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies.
Kuo KL; Ho IL; Shi CS; Wu JT; Lin WC; Tsai YC; Chang HC; Chou CT; Hsu CH; Hsieh JT; Chang SC; Pu YS; Huang KH
Cancer Lett; 2015 Jul; 363(2):127-36. PubMed ID: 25615422
[TBL] [Abstract][Full Text] [Related]
19. Targeting neddylation induces DNA damage and checkpoint activation and sensitizes chronic lymphocytic leukemia B cells to alkylating agents.
Paiva C; Godbersen JC; Berger A; Brown JR; Danilov AV
Cell Death Dis; 2015 Jul; 6(7):e1807. PubMed ID: 26158513
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic studies of substrate-assisted inhibition of ubiquitin-activating enzyme by adenosine sulfamate analogues.
Chen JJ; Tsu CA; Gavin JM; Milhollen MA; Bruzzese FJ; Mallender WD; Sintchak MD; Bump NJ; Yang X; Ma J; Loke HK; Xu Q; Li P; Bence NF; Brownell JE; Dick LR
J Biol Chem; 2011 Nov; 286(47):40867-77. PubMed ID: 21969368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
